ClouDr Group (HKSE:09955) Debt-to-EBITDA : -0.83 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is ClouDr Group Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

ClouDr Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$256 Mil. ClouDr Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$36 Mil. ClouDr Group's annualized EBITDA for the quarter that ended in Dec. 2023 was HK$-354 Mil. ClouDr Group's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.83.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for ClouDr Group's Debt-to-EBITDA or its related term are showing as below:

HKSE:09955' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -2.18 Med: -0.47 Max: -0.13
Current: -0.84

During the past 5 years, the highest Debt-to-EBITDA Ratio of ClouDr Group was -0.13. The lowest was -2.18. And the median was -0.47.

HKSE:09955's Debt-to-EBITDA is ranked worse than
100% of 75 companies
in the Medical Distribution industry
Industry Median: 2 vs HKSE:09955: -0.84

ClouDr Group Debt-to-EBITDA Historical Data

The historical data trend for ClouDr Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ClouDr Group Debt-to-EBITDA Chart

ClouDr Group Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-EBITDA

-0.47

-0.13

-2.18

-0.14

-1.28

ClouDr Group Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-EBITDA	Get a 7-Day Free Trial			-2.81	-0.03	-0.25	-0.95	-0.83

Competitive Comparison of ClouDr Group's Debt-to-EBITDA

For the Medical Distribution subindustry, ClouDr Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ClouDr Group's Debt-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, ClouDr Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where ClouDr Group's Debt-to-EBITDA falls into.

ClouDr Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

ClouDr Group's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(255.618	+	36.476)	/	-227.905
	=	-1.28

ClouDr Group's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(255.618	+	36.476)	/	-353.78
	=	-0.83

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.

ClouDr Group (HKSE:09955) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

ClouDr Group Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of ClouDr Group's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

ClouDr Group (HKSE:09955) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » ClouDr Group Ltd (HKSE:09955) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

H3L:Germany

Address

No. 998 Wenyi West Road (Haichuang Yuan), Wuchang Street, Rooms 501, 5th Floor, Building 12, Yuhang District, Zhejiang Province, Hangzhou, CHN

Website

https://www.cloudr.cn

ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. Its offerings include in-hospital solutions, pharmacy solutions, and individual chronic condition management solutions. The company's in-hospital solution consists of sales of medical devices, consumables and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies. It generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.

ClouDr Group (HKSE:09955) Headlines

No Headlines